Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement.

Transfusion medicine (Oxford, England)·2017
Same author

Prevention and treatment of coagulopathy in patients receiving massive transfusions.

Vox sanguinis·2011
Same author

Cardiac surgery with cardiopulmonary bypass: does aprotinin affect outcome?

British journal of anaesthesia·2007
Same author

The coagulopathy of massive transfusion.

Vox sanguinis·2005
Same author

Inadvertence refers to a lack of attention.

British journal of anaesthesia·2004

Related Experiment Video

Updated: May 20, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

[Erythrocyte transfusions: an evidence-based approach].

J-F Hardy1

  • 1Département d'anesthésiologie, centre hospitalier de l'université de Montréal, hôpital Notre-Dame, Qc, Canada. jean-francois.hardy@umontreal.ca

Annales Francaises D'Anesthesie Et De Reanimation
|July 17, 2012
PubMed
Summary

A restrictive red blood cell transfusion strategy (7-8 g/dL threshold) is as effective as a liberal strategy (10 g/dL threshold) for most patients. This approach reduces transfusion risks and adverse events without impacting patient outcomes.

Related Experiment Videos

Last Updated: May 20, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Area of Science:

  • Transfusion Medicine
  • Critical Care Medicine
  • Evidence-Based Medicine

Background:

  • Limited randomized controlled trials exist comparing restrictive vs. liberal red blood cell transfusion strategies.
  • Existing evidence suggests similar outcomes between different transfusion thresholds.

Purpose of the Study:

  • To review controlled studies on erythrocyte transfusion thresholds.
  • To evaluate the benefits and risks of restrictive versus liberal transfusion strategies.

Main Methods:

  • Systematic review of 19 controlled studies on erythrocyte transfusion thresholds published since the 1980s.

Main Results:

  • Morbidity, mortality, and hemodynamic/respiratory variables were similar between restrictive (7-8 g/dL) and liberal (10 g/dL) transfusion strategies.
  • Restrictive strategies may offer benefits, including reduced exposure to transfusions and fewer adverse events.
  • Anemia has minimal impact on functional recovery and quality of life post-operatively.

Conclusions:

  • Current transfusion practice recommendations lack robust evidence.
  • A restrictive transfusion strategy (7-8 g/dL) is appropriate for most patients.
  • High-quality trials are needed to establish optimal transfusion practices.